A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata
A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata
Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how safe, effective, and tolerable upadacitinib is in adolescent and adult participants with severe AA.
Upadacitinib is an approved drug being investigated for the treatment of AA. In Study 1 and Study 2 and Study 4 Period A, participants are placed in 1 of 3 groups, called treatment arms. Each group receives a different treatment. There is a 1 in 5 chance that participants will be assigned to placebo. In Study 1 and Study 2 and Study 4 Period B, participants originally randomized to upadacitinib dose group in Period A will continue their same treatment in Period B. Participants originally randomized to Placebo in Period A will either remain on placebo in Period B, or be randomized in 1 of 2 groups, based off of their Severity of Alopecia Tool (SALT) score. Participants who complete Study 1, Study 2 or Study 4, can join Study 3 and may be re-randomized to receive 1 of 2 doses of upadacitinib for up to 108 weeks. Around 1500 participants with severe AA will be enrolled in the study at approximately 280 sites worldwide.
Participants will receive oral tablets of either upadacitinib or placebo once daily for up to 160 weeks with the potential of being re-randomized into a different treatment group at Weeks 24 and 52. Participants will be followed up for up to 30 days after last study drug dose.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Inclusion Criteria:
Exclusion Criteria:
abbvieclinicaltrials@abbvie.com844-663-3742
Birmingham, Alabama 35205, United States
Glendale, Arizona 85308, United States
Phoenix, Arizona 85032, United States
Fort Smith, Arkansas 72916-6103, United States
Irvine, California 92697-1385, United States
Redwood City, California 94063, United States
Sacramento, California 95815, United States
Sacramento, California 95817, United States
Thousand Oaks, California 91320-2130, United States
Coral Gables, Florida 33134-5755, United States
Margate, Florida 33063, United States
Tampa, Florida 33607, United States
Dawsonville, Georgia 30534, United States
Chicago, Illinois 60611-2927, United States
Skokie, Illinois 60077, United States
Indianapolis, Indiana 46202, United States
New Orleans, Louisiana 70112, United States
Boston, Massachusetts 02135-3511, United States
Chesterfield, Michigan 48047, United States
Detroit, Michigan 48202-3046, United States
Grand Rapids, Michigan 49546, United States
Minneapolis, Minnesota 55455, United States
Lee's Summit, Missouri 64064-2301, United States
Lee's Summit, Missouri 64086, United States
Lincoln, Nebraska 68516, United States
New City, New York 10956-7153, United States
New York, New York 10029, United States
Cary, North Carolina 27511, United States
Huntersville, North Carolina 28078-7961, United States
Columbus, Ohio 43215, United States
Springfield, Ohio 45505, United States
Portland, Oregon 97223, United States
Pittsburgh, Pennsylvania 15213, United States
Charleston, South Carolina 29425, United States
Spartanburg, South Carolina 29307, United States
Murfreesboro, Tennessee 37130-2450, United States
Houston, Texas 77065, United States
Missouri City, Texas 77459, United States
San Antonio, Texas 78229, United States
Morgantown, West Virginia 26506, United States
Milwaukee, Wisconsin 53226, United States
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1055, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1425, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1425, Argentina
Buenos Aires, 1061, Argentina
Córdoba, 5000, Argentina
Darlinghurst, New South Wales 2010, Australia
Kogarah, New South Wales 2217, Australia
Woolloongabba, Queensland 4102, Australia
East Melbourne, Victoria 3002, Australia
Anderlecht, Brussels Capital 1070, Belgium
Brussels, Brussels Capital 1200, Belgium
Porto Alegre, Rio Grande do Sul 90020-090, Brazil
Campinas, São Paulo 13034-685, Brazil
Rio de Janeiro, 20241-180, Brazil
Sofiya, Sofia 1431, Bulgaria
Sofiya, Sofia 1463, Bulgaria
Sofiya, Sofia 1618, Bulgaria
Sofia, 1407, Bulgaria
Calgary, Alberta T2J 7E1, Canada
Edmonton, Alberta T5J 3S9, Canada
Surrey, British Columbia V3R 6A7, Canada
Barrie, Ontario L4M 7G1, Canada
Richmond Hill, Ontario L4C 9M7, Canada
Waterloo, Ontario N2J 1C4, Canada
Québec, Quebec G1V 4X7, Canada
Saint-Jérôme, Quebec J7Z 7E2, Canada
Las Condes, Region Metropolitana Santiago 7580206, Chile
Santiago, Region Metropolitana Santiago 8420383, Chile
Vitacura, Region Metropolitana Santiago 7640881, Chile
Independencia, Santiago Metropolitan 8380465, Chile
Beijing, Beijing Municipality 100020, China
Beijing, Beijing Municipality 100029, China
Beijing, Beijing Municipality 100044, China
Beijing, Beijing Municipality 100730, China
Chongqing, Chongqing Municipality 400010, China
Guangzhou, Guangdong 510080, China
Guangzhou, Guangdong 510091, China
Guangzhou, Guangdong 510163, China
Guangzhou, Guangdong 510280, China
Nanchang, Jiangxi 330030, China
Xi'an, Shaanxi 710004, China
Shanghai, Shanghai Municipality 200040, China
Taiyuan, Shanxi 030001, China
Chengdu, Sichuan 610017, China
Tianjin, Tianjin Municipality 300052, China
Hangzhou, Zhejiang 310009, China
Hangzhou, Zhejiang 310020, China
Wenzhou, Zhejiang 325000, China
Zagreb, City of Zagreb 10000, Croatia
Zagreb, City of Zagreb 10000, Croatia
Rijeka, Primorje-Gorski Kotar County 51000, Croatia
Split, Split-Dalmatia County 21000, Croatia
Bordeaux, Gironde 33000, France
Toulouse, Haute-Garonne 31400, France
Nantes, Pays de la Loire Region 44000, France
Düsseldorf, North Rhine-Westphalia 40225, Germany
Lübeck, Schleswig-Holstein 23538, Germany
Thessaloniki, 54643, Greece
Kecskemét, Bács-Kiskun county 6000, Hungary
Szeged, Csongrád megye 6725, Hungary
Debrecen, 4031, Hungary
Jerusalem, Jerusalem 91120, Israel
Florence, Firenze 50122, Italy
L’Aquila, L Aquila 67100, Italy
Naples, Napoli 80131, Italy
Naples, Napoli 80138, Italy
Rome, Roma 00133, Italy
Rome, Roma 00161, Italy
Rome, Roma 00168, Italy
Bologna, 40138, Italy
Milan, 20122, Italy
Kurume-shi, Fukuoka 830-0011, Japan
Sagamihara-shi, Kanagawa 252-0375, Japan
Niigata, Niigata 951-8520, Japan
Osaka, Osaka 545-8586, Japan
Mitaka-shi, Tokyo 181-8611, Japan
Shinjuku-ku, Tokyo 160-0023, Japan
Ube-shi, Yamaguchi 755-8505, Japan
Hamilton, Waikato Region 3204, New Zealand
Osielsko, Kuyavian-Pomeranian Voivodeship 86-031, Poland
Torun, Kuyavian-Pomeranian Voivodeship 87-100, Poland
Krakow, Lesser Poland Voivodeship 30-002, Poland
Warsaw, Masovian Voivodeship 00-716, Poland
Warsaw, Masovian Voivodeship 02-962, Poland
Bialystok, Podlaskie Voivodeship 15-351, Poland
Wroclaw, Pomeranian Voivodeship 54-429, Poland
Katowice, Silesian Voivodeship 40-615, Poland
Elblag, Warmian-Masurian Voivodeship 82-300, Poland
Almada, Setúbal District 2805-267, Portugal
Bratislava, Bratislava Region 811 07, Slovakia
Prešov, Presov 081 01, Slovakia
Busan, Busan Gwang Yeogsi 49241, South Korea
Daegu, Daegu Gwang Yeogsi 41944, South Korea
Daejeon, Daejeon Gwang Yeogsi 35015, South Korea
Seongnam-si, Gyeonggido 13620, South Korea
Incheon, Incheon Gwang Yeogsi 21565, South Korea
Jeonju, Jeonrabugdo 54907, South Korea
Seoul, Seoul Teugbyeolsi 03080, South Korea
Seoul, Seoul Teugbyeolsi 05030, South Korea
Seoul, Seoul Teugbyeolsi 05278, South Korea
Seoul, 05355, South Korea
L'Hospitalet de Llobregat, Barcelona 08907, Spain
Fuenlabrada, Madrid 28942, Spain
Solna, Stockholm County 171 64, Sweden
Stockholm, Stockholm County 111 37, Sweden
Ankara, Antalya 06010, Turkey (Türkiye)
Istanbul, 34214, Turkey (Türkiye)
Kayseri, 38039, Turkey (Türkiye)
High Wycombe, Buckinghamshire HP11 2QW, United Kingdom
Brighton, East Sussex BN2 5BE, United Kingdom
Gloucester, Gloucestershire GL1 3NN, United Kingdom
London, Greater London SW10 9NH, United Kingdom
Oxford, Oxfordshire OX3 9DU, United Kingdom
Harrow, HA1 3UJ, United Kingdom
916-551-2635
+1-561-948-3116
+1-561-948-3116
1-813-362-1037
504-988-5135
616-512-4445
402-697-6599
702 456 3120
775-336-3665
513-701-5526
864 574-0017 ext 8
512-260-5860
+86 010-85231777
+86 010-88326666
+86 027-85726114
+86 0531-87298808
+49 251 8356558
+4930450518176